Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more about BSX stock prospects.
Boston Beer Company faces declining beer consumption and underperforming brands, with a 43% stock drop since the last review. SAM's gross profit margin has improved due to high-margin offerings and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results